ebomi
The catalogIssuersInsidersTapeLicence
Colour theme
Theme
Sign in
Insider · CIK 0001257444

Alta Biopharma Partners III LP

CIK 0001257444 Name as filed on the most recent filing

Filed as Alta Biopharma Partners III LP (12)

47 transaction lines · from 12 filings · filed 2004-10-19 to 2014-02-05 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

0 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.

Transactions filed by this insider
Direction Date Issuer Code Shares Price Value USD Filing
2014-02-05 Cara Therapeutics, Inc.
CARA 		P, Open-market purchase 103,330 acquired 11.00 1,136,630.00 Form 4, filing 0001209191-14-007595
2014-02-05 Cara Therapeutics, Inc.
CARA 		P, Open-market purchase 6,940 acquired 11.00 76,340.00 Form 4, filing 0001209191-14-007595
2014-02-05 Cara Therapeutics, Inc.
CARA 		P, Open-market purchase 2,547 acquired 11.00 28,017.00 Form 4, filing 0001209191-14-007595
2012-10-16 Aegerion Pharmaceuticals, Inc.
AEGR 		S, Open-market sale 128,229 disposed 18.67 2,394,035.43 Form 4, filing 0001209191-12-049852
2012-10-16 Aegerion Pharmaceuticals, Inc.
AEGR 		S, Open-market sale 8,611 disposed 18.67 160,767.37 Form 4, filing 0001209191-12-049852
2012-10-16 Aegerion Pharmaceuticals, Inc.
AEGR 		S, Open-market sale 3,160 disposed 18.67 58,997.20 Form 4, filing 0001209191-12-049852
2012-10-15 Aegerion Pharmaceuticals, Inc.
AEGR 		S, Open-market sale 55,626 disposed 17.54 975,680.04 Form 4, filing 0001209191-12-049852
2012-10-15 Aegerion Pharmaceuticals, Inc.
AEGR 		S, Open-market sale 3,736 disposed 17.54 65,529.44 Form 4, filing 0001209191-12-049852
2012-10-15 Aegerion Pharmaceuticals, Inc.
AEGR 		S, Open-market sale 1,371 disposed 17.54 24,047.34 Form 4, filing 0001209191-12-049852
2011-08-09 Aegerion Pharmaceuticals, Inc.
AEGR 		P, Open-market purchase 5,038 acquired 12.45 62,743.25 Form 4, filing 0001209191-11-043220
2011-08-09 Aegerion Pharmaceuticals, Inc.
AEGR 		P, Open-market purchase 338 acquired 12.45 4,209.45 Form 4, filing 0001209191-11-043220
2011-08-09 Aegerion Pharmaceuticals, Inc.
AEGR 		P, Open-market purchase 124 acquired 12.45 1,544.30 Form 4, filing 0001209191-11-043220
2011-08-08 Aegerion Pharmaceuticals, Inc.
AEGR 		P, Open-market purchase 3,847 acquired 12.43 47,816.67 Form 4, filing 0001209191-11-043220
2011-08-08 Aegerion Pharmaceuticals, Inc.
AEGR 		P, Open-market purchase 258 acquired 12.43 3,206.84 Form 4, filing 0001209191-11-043220
2011-08-08 Aegerion Pharmaceuticals, Inc.
AEGR 		P, Open-market purchase 95 acquired 12.43 1,180.81 Form 4, filing 0001209191-11-043220
2010-10-27 Aegerion Pharmaceuticals, Inc.
AEGR 		P, Open-market purchase 289,236 acquired 9.50 2,747,742.00 Form 4, filing 0001209191-10-051904
2010-10-27 Aegerion Pharmaceuticals, Inc.
AEGR 		P, Open-market purchase 19,425 acquired 9.50 184,537.50 Form 4, filing 0001209191-10-051904
2010-10-27 Aegerion Pharmaceuticals, Inc.
AEGR 		P, Open-market purchase 7,128 acquired 9.50 67,716.00 Form 4, filing 0001209191-10-051904
2010-06-30 Sunesis Pharmaceuticals Inc
SNSS 		P, Open-market purchase 10,910,596 acquired 0.28 3,000,413.90 Form 4, filing 0001209191-10-036944
2010-06-30 Sunesis Pharmaceuticals Inc
SNSS 		P, Open-market purchase 732,745 acquired 0.28 201,504.88 Form 4, filing 0001209191-10-036944
2010-06-30 Sunesis Pharmaceuticals Inc
SNSS 		P, Open-market purchase 268,883 acquired 0.28 73,942.82 Form 4, filing 0001209191-10-036944
2009-12-14 Sunesis Pharmaceuticals Inc
SNSS 		S, Open-market sale 2,044,750 disposed 2.01 4,108,720.65 Form 4, filing 0001209191-09-057467
2009-12-14 Sunesis Pharmaceuticals Inc
SNSS 		S, Open-market sale 137,323 disposed 2.01 275,936.84 Form 4, filing 0001209191-09-057467
2009-12-14 Sunesis Pharmaceuticals Inc
SNSS 		S, Open-market sale 50,391 disposed 2.01 101,255.68 Form 4, filing 0001209191-09-057467
2009-10-05 Threshold Pharmaceuticals Inc
THLD 		P, Open-market purchase 239,768 acquired 1.91 457,956.88 Form 4, filing 0001209191-09-047812
2009-10-05 Threshold Pharmaceuticals Inc
THLD 		P, Open-market purchase 16,103 acquired 1.91 30,756.73 Form 4, filing 0001209191-09-047812
2009-10-05 Threshold Pharmaceuticals Inc
THLD 		P, Open-market purchase 5,909 acquired 1.91 11,286.19 Form 4, filing 0001209191-09-047812
2009-09-08 TorreyPines Therapeutics, Inc.
TPTX 		S, Open-market sale 238,256 disposed 0.22 52,297.19 Form 4, filing 0001209191-09-043545
2009-09-08 TorreyPines Therapeutics, Inc.
TPTX 		S, Open-market sale 103,618 disposed 0.22 22,744.15 Form 4, filing 0001209191-09-043545
2009-09-08 TorreyPines Therapeutics, Inc.
TPTX 		S, Open-market sale 67,879 disposed 0.22 14,899.44 Form 4, filing 0001209191-09-043545
2009-09-08 TorreyPines Therapeutics, Inc.
TPTX 		S, Open-market sale 6,959 disposed 0.22 1,527.50 Form 4, filing 0001209191-09-043545
2009-09-08 TorreyPines Therapeutics, Inc.
TPTX 		S, Open-market sale 3,010 disposed 0.22 660.70 Form 4, filing 0001209191-09-043545
2009-09-08 TorreyPines Therapeutics, Inc.
TPTX 		S, Open-market sale 2,553 disposed 0.22 560.38 Form 4, filing 0001209191-09-043545
2009-09-03 TorreyPines Therapeutics, Inc.
TPTX 		S, Open-market sale 166,762 disposed 0.23 38,805.52 Form 4, filing 0001209191-09-043545
2009-09-03 TorreyPines Therapeutics, Inc.
TPTX 		S, Open-market sale 72,525 disposed 0.23 16,876.57 Form 4, filing 0001209191-09-043545
2009-09-03 TorreyPines Therapeutics, Inc.
TPTX 		S, Open-market sale 47,510 disposed 0.23 11,055.58 Form 4, filing 0001209191-09-043545
2009-09-03 TorreyPines Therapeutics, Inc.
TPTX 		S, Open-market sale 4,871 disposed 0.23 1,133.48 Form 4, filing 0001209191-09-043545
2009-09-03 TorreyPines Therapeutics, Inc.
TPTX 		S, Open-market sale 2,107 disposed 0.23 490.30 Form 4, filing 0001209191-09-043545
2009-09-03 TorreyPines Therapeutics, Inc.
TPTX 		S, Open-market sale 1,787 disposed 0.23 415.83 Form 4, filing 0001209191-09-043545
2005-10-14 Cotherix Inc
CTRX 		S, Open-market sale 152,900 disposed 13.00 1,987,700.00 Form 4, filing 0001209191-05-052704
2005-10-14 Cotherix Inc
CTRX 		S, Open-market sale 10,268 disposed 13.00 133,484.00 Form 4, filing 0001209191-05-052704
2005-10-14 Cotherix Inc
CTRX 		S, Open-market sale 3,769 disposed 13.00 48,997.00 Form 4, filing 0001209191-05-052704
2005-10-12 Cotherix Inc
CTRX 		S, Open-market sale 226,519 disposed 13.00 2,944,747.00 Form 4, filing 0001209191-05-052406
2005-10-12 Cotherix Inc
CTRX 		S, Open-market sale 15,213 disposed 13.00 197,769.00 Form 4, filing 0001209191-05-052406
2005-10-12 Cotherix Inc
CTRX 		S, Open-market sale 5,582 disposed 13.00 72,566.00 Form 4, filing 0001209191-05-052406
2004-10-15 Cotherix Inc
CTRX 		P, Open-market purchase 358,426 acquired 6.00 2,150,556.00 Form 4, filing 0001209191-04-049151
2004-10-15 Cotherix Inc
CTRX 		P, Open-market purchase 416,666 acquired 6.00 2,499,996.00 Form 4, filing 0001209191-04-048864

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
P, Open-market purchase
Open-market purchase
S, Open-market sale
Open-market sale

Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.

What this insider's stored lines contain

No transaction line is stored for this entity, so there is nothing to break down by code. The catalog holds its filings; what it does not hold is a single reportable line from them, which is a fact about the parse and about these filings, not about the entity.

How to cite this page

ebomi catalog. ALTA BIOPHARMA PARTNERS III LP, insider transactions. Retrieved 2026-08-20 from https://ebomi.com/insider/0001257444

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.